康(kang)(kang)龍(long)(long)(long)化(hua)(hua)成(cheng)(cheng)新(xin)藥(yao)(yao)(yao)技術股份(fen)有(you)限(xian)公(gong)(gong)司(si),成(cheng)(cheng)立于2004年(nian),是國(guo)際生命(ming)科學(xue)研(yan)(yan)(yan)發(fa)(fa)服(fu)務企業(ye)。公(gong)(gong)司(si)使(shi)命(ming)為“以高水平(ping)的(de)研(yan)(yan)(yan)發(fa)(fa)服(fu)務,幫助(zhu)合(he)作(zuo)(zuo)伙伴們成(cheng)(cheng)功開發(fa)(fa)新(xin)藥(yao)(yao)(yao),為人類健康(kang)(kang)貢獻康(kang)(kang)龍(long)(long)(long)化(hua)(hua)成(cheng)(cheng)智慧。”經過十(shi)多年(nian)的(de)發(fa)(fa)展,康(kang)(kang)龍(long)(long)(long)化(hua)(hua)成(cheng)(cheng)打造了藥(yao)(yao)(yao)物(wu)(wu)研(yan)(yan)(yan)發(fa)(fa)一體(ti)化(hua)(hua)平(ping)臺,貫穿合(he)成(cheng)(cheng)與(yu)藥(yao)(yao)(yao)物(wu)(wu)化(hua)(hua)學(xue)、生物(wu)(wu)、藥(yao)(yao)(yao)物(wu)(wu)代謝及藥(yao)(yao)(yao)代動(dong)力(li)學(xue)、藥(yao)(yao)(yao)理(li)、藥(yao)(yao)(yao)物(wu)(wu)安全評價、放射標記代謝、工藝研(yan)(yan)(yan)發(fa)(fa)、GMP生產及制劑(ji)研(yan)(yan)(yan)發(fa)(fa)服(fu)務等(deng)各個領域,提(ti)供(gong)包(bao)括苗(miao)頭(tou)化(hua)(hua)合(he)物(wu)(wu)探索(suo)與(yu)靶標驗證、先導化(hua)(hua)合(he)物(wu)(wu)優化(hua)(hua)、臨床前候選藥(yao)(yao)(yao)物(wu)(wu)篩選、新(xin)藥(yao)(yao)(yao)臨床開發(fa)(fa)和新(xin)藥(yao)(yao)(yao)上市申報等(deng)一體(ti)化(hua)(hua)服(fu)務。康(kang)(kang)龍(long)(long)(long)化(hua)(hua)成(cheng)(cheng)在中國(guo)、美國(guo)、英國(guo)均有(you)運營實(shi)體(ti),擁有(you)7000多名員工,人才隊(dui)伍,高質量的(de)研(yan)(yan)(yan)發(fa)(fa)服(fu)務,獲得(de)了業(ye)界的(de)廣泛認可(ke),與(yu)北(bei)美、歐洲、日(ri)本(ben)和中國(guo)的(de)各醫藥(yao)(yao)(yao)公(gong)(gong)司(si)/機構保持著穩(wen)固的(de)合(he)作(zuo)(zuo)關系。